Information Provided By:
Fly News Breaks for October 17, 2019
AMED
Oct 17, 2019 | 08:55 EDT
Deutsche Bank analyst Justin Bowers placed a "Catalyst Call" buy on shares of Amedisys as a short-term investment idea. Due primarily to better than expected accretion from recent hospice acquisitions, the analyst expects Amedisys to beat the Q3 earnings consensus estimate by 6c and raise its full-year guidance. Further, he expects the Centers for Medicare and Medicaid home health final rule to publish late October or early November. If the final rule provides relief to the current down 8% behavioral assumption, the market would view this as a positive surprise given the "significant upside to 2020 consensus estimates under such an outcome," Bowers tells investors in a research note. He keeps a Buy rating on Amedisys shares.
News For AMED From the Last 2 Days
There are no results for your query AMED